BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19394967)

  • 21. Valproic acid induces Notch1 signaling in small cell lung cancer cells.
    Platta CS; Greenblatt DY; Kunnimalaiyaan M; Chen H
    J Surg Res; 2008 Jul; 148(1):31-7. PubMed ID: 18570928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells.
    Huang X; Guo B
    Cancer Res; 2006 Sep; 66(18):9245-51. PubMed ID: 16982769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.
    Jang S; Jin H; Roy M; Ma AL; Gong S; Jaskula-Sztul R; Chen H
    Cancer Med; 2017 Sep; 6(9):2142-2152. PubMed ID: 28776955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lithium ions: a novel treatment for pheochromocytomas and paragangliomas.
    Kappes A; Vaccaro A; Kunnimalaiyaan M; Chen H
    Surgery; 2007 Feb; 141(2):161-5; discussion 165. PubMed ID: 17263970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproate recovers the inhibitory effect of dexamethasone on the proliferation of the adult dentate gyrus-derived neural precursor cells via GSK-3β and β-catenin pathway.
    Boku S; Nakagawa S; Masuda T; Nishikawa H; Kato A; Takamura N; Omiya Y; Kitaichi Y; Inoue T; Kusumi I
    Eur J Pharmacol; 2014 Jan; 723():425-30. PubMed ID: 24211784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression.
    Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
    HPB (Oxford); 2015 Sep; 17(9):770-6. PubMed ID: 26147011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyper-activation of WNT/β-catenin signaling pathway mediates anti-tumor effects of histone deacetylase inhibitors in acute T lymphoblastic leukemia.
    Shao N; Zou J; Li J; Chen F; Dai J; Qu X; Sun X; Ma D; Ji C
    Leuk Lymphoma; 2012 Sep; 53(9):1769-78. PubMed ID: 22303878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lithium inhibits proliferation of human esophageal cancer cell line Eca-109 by inducing a G2/M cell cycle arrest.
    Wang JS; Wang CL; Wen JF; Wang YJ; Hu YB; Ren HZ
    World J Gastroenterol; 2008 Jul; 14(25):3982-9. PubMed ID: 18609681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valproic Acid and Lithium Meditate Anti-Inflammatory Effects by Differentially Modulating Dendritic Cell Differentiation and Function.
    Leu SJ; Yang YY; Liu HC; Cheng CY; Wu YC; Huang MC; Lee YL; Chen CC; Shen WW; Liu KJ
    J Cell Physiol; 2017 May; 232(5):1176-1186. PubMed ID: 27639185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
    Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
    Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The heat shock protein 90 inhibitor SNX5422 has a synergistic activity with histone deacetylase inhibitors in induction of death of anaplastic thyroid carcinoma cells.
    Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Endocrine; 2016 Feb; 51(2):274-82. PubMed ID: 26219406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel histone deacetylase inhibitors in the treatment of thyroid cancer.
    Mitsiades CS; Poulaki V; McMullan C; Negri J; Fanourakis G; Goudopoulou A; Richon VM; Marks PA; Mitsiades N
    Clin Cancer Res; 2005 May; 11(10):3958-65. PubMed ID: 15897598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproic acid promotes human hair growth in in vitro culture model.
    Jo SJ; Choi SJ; Yoon SY; Lee JY; Park WS; Park PJ; Kim KH; Eun HC; Kwon O
    J Dermatol Sci; 2013 Oct; 72(1):16-24. PubMed ID: 23810771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.
    Hall AC; Brennan A; Goold RG; Cleverley K; Lucas FR; Gordon-Weeks PR; Salinas PC
    Mol Cell Neurosci; 2002 Jun; 20(2):257-70. PubMed ID: 12093158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproic acid sensitizes TRAIL-resistant anaplastic thyroid carcinoma cells to apoptotic cell death.
    Cha HY; Lee BS; Kang S; Shin YS; Chang JW; Sung ES; Kim YS; Choi JW; Kim JH; Kim CH
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S716-24. PubMed ID: 23982257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
    Wang HM; Zhang T; Li Q; Huang JK; Chen RF; Sun XJ
    Neurochem Int; 2013 Nov; 63(5):345-53. PubMed ID: 23871716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.
    Silva R; Mesquita AR; Bessa J; Sousa JC; Sotiropoulos I; Leão P; Almeida OF; Sousa N
    Neuroscience; 2008 Mar; 152(3):656-69. PubMed ID: 18291594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail.
    Feng J; Cen J; Li J; Zhao R; Zhu C; Wang Z; Xie J; Tang W
    Cell Adh Migr; 2015; 9(6):495-501. PubMed ID: 26632346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas.
    Atkins RJ; Dimou J; Paradiso L; Morokoff AP; Kaye AH; Drummond KJ; Hovens CM
    J Clin Neurosci; 2012 Nov; 19(11):1558-63. PubMed ID: 22999562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of Nrf2 by the combination of TRAIL and Valproic acid induces apoptotic cell death of TRAIL-resistant papillary thyroid cancer cells via suppression of Bcl-xL.
    Cha HY; Lee BS; Chang JW; Park JK; Han JH; Kim YS; Shin YS; Byeon HK; Kim CH
    Cancer Lett; 2016 Mar; 372(1):65-74. PubMed ID: 26721202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.